Clean Slate Clinic Raises $4.3M for Detox Services

Clean Slate Clinic, a pioneering social enterprise focused on remote alcohol detoxification, has successfully closed a significant capital raise totaling $4.3 million. This funding injection, comprising a $2.8 million convertible note and a $1.5 million debt facility, positions the company for substantial growth and upcoming Series A expansion plans.

The convertible note was supported by prominent impact investor Giant Leap and existing shareholder Scale Investors. Concurrently, long-term supporter Australian Medical Angels provided a crucial debt facility, underscoring confidence in the clinic's innovative model. Founded in 2020, Clean Slate Clinic has already assisted over 3,000 individuals in managing withdrawal from alcohol, stimulants, and cannabis within the comfort of their own homes.

This funding round precedes a planned $10 million Series A round anticipated in 2027, which will fuel international expansion, notably into the United Kingdom, and further market penetration. The demand for accessible, clinician-led home detox solutions is substantial, with an estimated 1.4 million Australians requiring specialist care for alcohol consumption levels, yet a significant treatment gap persists. Dr. Chris Davis, a co-founder and practicing GP, highlighted that fewer than a quarter of individuals with alcohol dependence seek professional help, often delaying this critical step for years due to a lack of scalable, community-based support.

“The Australian healthcare system frequently encounters alcohol-related crises, yet safe, medically supervised detoxification at home has been largely unavailable at scale,” stated Dr. Davis. “Clean Slate Clinic fundamentally alters this dynamic by offering immediate medical access to individuals when they are prepared to address their dependency, thereby preventing the cyclical nature of crisis intervention.”

Giant Leap partner Rachel Yang commented on the compelling nature of Clean Slate Clinic's offering, emphasizing its dual impact: addressing the significant societal stigma surrounding addiction treatment and modernizing outdated care models. “The accessibility and profound clinical benefits are matched by robust commercial traction,” Yang noted. “The company has demonstrated impressive year-over-year growth and has successfully negotiated reimbursement agreements with most major private health insurers in Australia. This represents a rare instance where a solution benefits patients, payers, and the broader healthcare infrastructure simultaneously.”

The success of Clean Slate Clinic aligns with a growing global trend towards digital health solutions and a greater emphasis on mental and behavioral health services. The digital therapeutics market is projected to experience significant expansion in the coming years, driven by increased patient acceptance, technological advancements, and favorable reimbursement policies. Clean Slate Clinic's model, which integrates medical expertise with convenient home-based care, is well-positioned to capture a significant share of this evolving market.